Advertisements



We are Sorry, This Page doesn't Exist


Pfizer profit misses as breast cancer drug sales fall short of estimates

Pfizer Inc posted a quarterly profit on Tuesday that came in below Wall Street estimates, as sales of breast cancer drug Ibrance fell short of expectations......»»

Category: topSource: reutersJan 28th, 2020

Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge

Pfizer Inc posted third-quarter profit well above analysts' estimates on higher sales of cancer drug Ibrance and new heart medicine Vyndaqel, encouraging the largest U.S. drugmaker to lift its earnings forecast for the year......»»

Category: topSource: reutersOct 29th, 2019

Pfizer raises 2019 forecast on surging cancer drug sales

Pfizer Inc posted third-quarter profit well above analysts' estimates on higher sales of cancer drug Ibrance and arthritis medicine Xeljanz, encouraging the largest U.S. drugmaker to lift its earnings forecast for the year......»»

Category: topSource: reutersOct 29th, 2019

Pfizer posts earnings beat, raises 2019 profit forecast

Pfizer Inc beat Wall Street estimates for quarterly profit and tweaked its earnings forecast for the year on Tuesday, as it reported rising sales of cancer drug Ibrance and pneumonia vaccine Prevnar, pushing shares in the drugmaker higher......»»

Category: topSource: reutersApr 30th, 2019

Keytruda sales power Merck to quarterly beat

(Reuters) - Drugmaker Merck & Co reported a better-than-expected first-quarter profit on Tuesday, helped by a more than 150 percent rise in sales of cancer drug Keytruda......»»

Category: topSource: reutersMay 1st, 2018

Pfizer first-quarter results miss estimates as key drug sales fall short

NEW YORK (Reuters) - Pfizer Inc on Tuesday reported lower-than-expected first-quarter revenue as demand for some key drugs and international sales fell short of estimates, sparking a 5.1 percent drop in shares of the largest U.S. drugmaker......»»

Category: topSource: reutersMay 1st, 2018

J&J beats quarterly expectations on drug sales surge, shares jump

Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent......»»

Category: topSource: reutersJul 17th, 2018

CVS Health profit beats on higher prescription drug sales

Drugstore retailer CVS Health Corp's adjusted quarterly profit topped analyst estimates on Wednesday as it sold more prescription drugs at its stores, sending its shares up 3.4 percent in premarket trading......»»

Category: topSource: reutersAug 8th, 2018

Twitter ad sales surge in third quarter, shares jump

Twitter Inc posted revenue and profit ahead of Wall Street estimates on Thursday, as higher advertising sales offset a drop in monthly users to push the company's shares up nearly 12 percent before the opening bell......»»

Category: topSource: reutersOct 25th, 2018

Twitter ad sales surge in third quarter, shares jump

Twitter Inc posted revenue and profit ahead of Wall Street estimates on Thursday, as higher advertising sales offset a drop in monthly users to push the company's shares up nearly 12 percent before the opening bell......»»

Category: topSource: moneycentralOct 25th, 2018

AbbVie lifts profit target after cancer drug powers quarterly beat

AbbVie Inc beat Wall Street estimates for third-quarter profit on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica, and the drugmaker raised its 2018 earnings forecast, sending its shares up 4 percent......»»

Category: topSource: reutersNov 2nd, 2018

Pfizer quarterly profit in line, touts pipeline of future products

Pfizer Inc on Tuesday reported fourth-quarter profit and sales that edged past Wall Street estimates, helped by higher sales of breast cancer medicine Ibrance and pain drug Lyrica......»»

Category: topSource: reutersJan 29th, 2019

Pfizer’s COVID-19 vaccine lifts quarterly results

Pfizer Inc. significantly increased revenue projections from its Covid-19 vaccine for the year, as sales from the shot over the first three months of 2021 lifted the company to a stronger quarterly profit......»»

Category: topSource: foxnewsMay 4th, 2021

Sanofi Swings To Forth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By €500M

Sanofi SA (NASDAQ: SNY) posted a profit for the fourth quarter of 2020 .....»»

Category: earningsSource: benzingaFeb 5th, 2021

Pfizer stock slips after profit misses expectations, while revenue beats

Shares of Pfizer Inc. slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an upbeat full-year outlook. The company swung to net income .....»»

Category: topSource: marketwatchFeb 2nd, 2021

J&J Covid-19 vaccine data due "soon" as drug maker boosts outlook

The world’s biggest maker of health care products topped profit and sales expectations......»»

Category: topSource: foxnewsJan 26th, 2021

Nike powers through pandemic with digital push

Sportswear giant reports higher profit and revenue, boosted by China and 84% jump in digital sales.....»»

Category: topSource: foxnewsDec 20th, 2020

CVS Health profit spikes as coronavirus drives sales surge

CVS Health's first-quarter profit spiked 41 percent year-over-year to $2.01 billion......»»

Category: topSource: foxnewsMay 6th, 2020

McDonald"s profit sinks as coronavirus slams sales

The Chicago-based fast-food chain reported first-quarter profit fell 16 percent to $1.1 billion, or $1.47 a share, on revenue of $4.71 billion......»»

Category: topSource: foxnewsApr 30th, 2020

Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales

Novartis on Wednesday won a new European approval for its inflammation drug Cosentyx in a form of arthritis, as the Swiss drugmaker predicts broadening use of its top-selling medicine will eventually push annual sales beyond $5 billion......»»

Category: topSource: reutersApr 29th, 2020